Biocept Obtains $3,600,000 New Financing Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=58d3ac41-64a6-4e2d-9091-a38a93e3a8eb&Preview=1 - Date
3/30/2010 - Company Name
Biocept - Mailing Address
5810 Nancy Ridge Drive San Diego, CA 92121 - Company Description
Biocept is an emerging leader in genetic testing. The company’s proprietary CEE Cell Enrichment and Extraction technology is designed to isolate and extract rare cells for highly accurate genetic analysis. CEE will be used exclusively in Biocept Laboratories’ first product, preCEEd” prenatal diagnostic. This in-house-developed test will be performed in Biocept’s CLIA certified laboratory. preCEEd will enable reliable first-trimester diagnosis with the ease of a cervical swab. - Website
http://www.biocept.com - Transaction Type
Venture Equity - Transaction Amount
$3,600,000 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. - M&A Terms
- Venture Investor
Undisclosed
